|1.||Schunk, Stefan: 2 articles (08/2014 - 08/2014)|
|2.||Zemolka, Saskia: 2 articles (08/2014 - 08/2014)|
|3.||Oberbörsch, Stefan: 2 articles (08/2014 - 08/2014)|
|4.||Saunders, Derek: 2 articles (08/2014 - 08/2014)|
|5.||Germann, Tieno: 2 articles (08/2014 - 08/2014)|
|6.||Englberger, Werner: 2 articles (08/2014 - 08/2014)|
|7.||Harlfinger, Stephanie: 2 articles (08/2014 - 08/2014)|
|8.||Hinze, Claudia: 2 articles (08/2014 - 08/2014)|
|9.||Kögel, Babette-Y: 2 articles (08/2014 - 08/2014)|
|10.||Sonnenschein, Helmut: 2 articles (08/2014 - 08/2014)|
02/01/2009 - "(18)F-trans-4-fluoro-N-2-[4-(2-methoxyphenyl) piperazin-1-yl]ethyl-N-(2-pyridyl)cyclohexane carboxamide ((18)F-FCWAY) PET may show more specific 5-HT(1A)-receptor binding reduction in seizure initiation than in propagation regions. "
01/01/1999 - "All Merz amino-alkyl-cyclohexane derivatives inhibited MES-induced convulsions in mice with ED50s ranging from 3.6 to 130 mg/kg i.p. "
04/11/2003 - "In the present study, various nicotinic acetylcholine receptor antagonists, including novel amino-alkyl-cyclohexane derivatives, were evaluated in two animal models, namely the maximal electroshock seizure test in mice and amygdala-kindling in rats. "
01/01/1999 - "The present study characterized the in vitro NMDA receptor antagonistic properties of novel amino-alkyl-cyclohexane derivatives and compared these effects with their ability to block excitotoxicity in vitro and MES-induced convulsions in vivo. "
03/01/1995 - "The anticonvulsant gabapentin (1-(aminomethyl)cyclohexane acetic acid) has been found to be effective for treatment of partial seizures, but the mechanism of action is unknown. "
06/01/1987 - "Gabapentin, 1-(aminomethyl) cyclohexane acetic acid, is a GABA analogue whose antiepileptic properties were tested in a double blind cross-over trial design as add-on therapy in a dose ranging study which compared 300 mg, 600 mg, and 900 mg/day (each dose given for 2 months) in 25 patients with severe partial and generalised epilepsies. "
11/01/2001 - "Pregabalin [(S)-(+)-3-isobutylgaba] and gabapentin [1-(aminomethyl)cyclohexane acetic acid] are gamma-aminobutyric acid (GABA) derivatives that are effective in the treatment of behavioural disorders, convulsions, epilepsy and hyperalgesia. "
06/15/1990 - "Collectively, the present study demonstrates that cyclohexane is more effective as a stage II tumor promoter over mouse skin and possibly affects the biochemical events at the molecular level."
06/15/1990 - "Inhibitors of stage II tumor promotion showed more effect on the ODC induction by cyclohexane as compared to the inhibitors of stage I tumor promotion. "
07/11/2013 - "Derivative 5-bromo-3'-(cyclohexane carbonyl)-1-methyl-2-oxospiro[indoline-3,2'-thiazolidine] (4n) emerged as the most potent compound of this series, inhibiting in vitro 30% of p53-MDM2 interaction at 5 μM and the cell growth of different human tumor cells at nanomolar concentrations. "
05/01/2013 - "Fumagillin, a cyclohexane isolated from fungus Aspergillus fumigatus, has anti-infective and anti-cancer potency. "
12/01/2004 - "To determine whether radiation combined with Trans-4-AminoMethyl Cyclohexane carboxylic Acid (AMCA, or tranexamic acid, Cyklokapron) results in a better tumor response than radiation alone. "
|1.||Acetic Acid (Vinegar)
|3.||gamma-Aminobutyric Acid (GABA)
|4.||Tranexamic Acid (AMCA)
|7.||5-HT1A Serotonin Receptor